Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.

NCT00150423 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00150423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00150423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2001
Completion date
July 31, 2005
Enrollment
384
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy, painful